| 737378 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective |
2021-09-01 |
10.1016/j.biopha.2021.112193 |
Al-kuraishy Hayder M., Al-Gareeb Ali I., Qusti Safaa, Alshammari Eida M., Atanu Francis O., Batiha Gaber El-Saber |
| 737377 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19? |
2021-09-01 |
10.1016/j.biopha.2021.111922 |
Farella Ilaria, Panza Raffaella, Capozza Manuela, Laforgia Nicola |
| 737376 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options |
2021-09-01 |
10.1016/j.biopha.2021.111794 |
Dyavar Shetty Ravi, Singh Rahul, Emani Rohini, Pawar Ganesh P., Chaudhari Vinod D., Podany Anthony T., Avedissian Sean N., Fletcher Courtney V., Salunke Deepak B. |
| 737375 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2 |
2021-09-01 |
10.1016/j.biopha.2021.111902 |
Morsy Mohamed A., Khalaf Hanaa M., Rifaai Rehab A., Bayoumi Asmaa M.A., Khalifa Esraa M.M.A., Ibrahim Yasmine F. |
| 737374 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Molecular mechanism of DLBS3733, a bioactive fraction of Lagerstroemia speciosa (L.) Pers., on ameliorating hepatic lipid accumulation in HepG2 cells |
2021-09-01 |
10.1016/j.biopha.2021.111937 |
Tandrasasmita Olivia M., Berlian Guntur, Tjandrawinata Raymond R. |
| 737373 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Anti-allergic effects of Asarum heterotropoides on an ovalbumin-induced allergic rhinitis murine model |
2021-09-01 |
10.1016/j.biopha.2021.111944 |
Choi Susanna, Jung Myung-A, Hwang Youn-Hwan, Pyun Bo-Jeong, Lee Joo Young, Jung Dong Ho, Ji Kon-Young, Kim Taesoo |
| 737372 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
QiShenYiQi ameliorates salt-induced hypertensive nephropathy by balancing ADRA1D and SIK1 expression in Dahl salt-sensitive rats |
2021-09-01 |
10.1016/j.biopha.2021.111941 |
Du Hongxia, Xiao Guangxu, Xue Zhifeng, Li Zhixiong, He Shuang, Du Xiaoli, Zhou Zhengchan, Cao Linghua, Wang Yule, Yang Jian, Wang Xiaoying, Zhu Yan |
| 737371 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Effects of Naodesheng tablets on amyloid beta-induced dysfunction: A traditional Chinese herbal formula with novel therapeutic potential in Alzheimer's disease revealed by systems pharmacology |
2021-09-01 |
10.1016/j.biopha.2021.111916 |
Zhang Baoyue, Zhao Jun, Guo Pengfei, Wang Zhe, Xu Lvjie, Liu Ailin, Du Guanhua |
| 737370 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach |
2021-09-01 |
10.1016/j.biopha.2021.111940 |
Waghule Tejashree, Dabholkar Neha, Gorantla Srividya, Rapalli Vamshi Krishna, Saha Ranendra Narayan, Singhvi Gautam |
| 737369 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Evaluation of the effects of metformin as adenosine monophosphate-activated protein kinase activator on spatial learning and memory in a rat model of multiple sclerosis disease |
2021-09-01 |
10.1016/j.biopha.2021.111932 |
Arabmoazzen Saiedeh, Mirshekar Mohammad Ali |
